Factory Mutual Insurance’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-41,000
Closed -$2.74M 176
2024
Q3
$2.74M Hold
41,000
0.03% 169
2024
Q2
$4.87M Hold
41,000
0.06% 161
2024
Q1
$4.37M Hold
41,000
0.05% 162
2023
Q4
$4.08M Hold
41,000
0.05% 155
2023
Q3
$4.23M Hold
41,000
0.06% 147
2023
Q2
$4.98M Hold
41,000
0.07% 136
2023
Q1
$6.3M Hold
41,000
0.1% 137
2022
Q4
$7.36M Hold
41,000
0.11% 134
2022
Q3
$4.85M Hold
41,000
0.08% 137
2022
Q2
$5.86M Hold
41,000
0.1% 135
2022
Q1
$7.06M Hold
41,000
0.1% 129
2021
Q4
$5.87M Buy
+41,000
New +$12M 0.08% 128

Other funds holding MRNA

Factory Mutual Insurance's MRNA Position: Q4 2024 in Review

Factory Mutual Insurance sold out of Moderna (MRNA) in Q4 2024, closing a stake of 41,000 shares — an estimated $2.74M sold.

Factory Mutual Insurance first reported a position in MRNA in Q4 2021 and held it in 12 quarters. The position peaked at $7.36M in Q4 2022. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Factory Mutual Insurance reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Factory Mutual Insurance sold 41,000 Moderna shares in Q4 2024, an estimated $2.74M.
  • Factory Mutual Insurance first reported a position in Moderna in Q4 2021 and held it in 12 quarters.
  • Factory Mutual Insurance's Moderna position peaked at $7.36M in Q4 2022.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Factory Mutual Insurance's 13F filing for Q4 2024, filed 24 Jan 2025.